Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model - PubMed (original) (raw)
doi: 10.1093/ndt/gfi177. Epub 2005 Oct 12.
Affiliations
- PMID: 16221709
- DOI: 10.1093/ndt/gfi177
Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model
Evangelia Spandou et al. Nephrol Dial Transplant. 2006 Feb.
Abstract
Background: Erythropoietin (EPO), originally identified for its critical role in promoting erythrocyte survival and differentiation, has been shown to exert multiple paracrine/autocrine functions. Protective effects of EPO have been demonstrated in various tissues and experimental models of ischaemia-induced injury. In the present study, we investigated the effect of EPO on an in vivo rat model of renal ischaemia/reperfusion (I/R) injury and the possible mechanisms implicated in the EPO-mediated anti-apoptotic action.
Methods: Male Wistar rats, subjected to renal ischaemia for 45 min, were administered either saline or EPO (500 U/kg, i.p.) 20 min prior to I/R. A sham-operated group served as the control. At 48 h of reperfusion, the renal dysfunction and injury was assessed by measurement of serum biochemical markers (urea, creatinine) and histological grading. Apoptosis was assessed by the TUNEL method and morphological criteria. Expression of Bax and NF-kappaB (p65) was also evaluated.
Results: High levels of serum urea and creatinine were identified at 48 h after ischaemia. The EPO-treated group had significantly lower serum and creatinine levels. Semi-quantitative assessment of the histological lesions showed that rats subjected to I/R developed marked structural damage, whereas significantly less tubular damage was observed in the EPO-treated group. I/R caused an increase in TUNEL-positive cells that was accompanied by morphological evidence of apoptosis. In the EPO-treated rats only a few scattered TUNEL-positive cells were observed. Up-regulation of Bax in the tubular epithelial cells and increased expression of NF-kappaB was observed in the I/R-treated rats, while diminished expression of Bax and positive immunostaining of NF-kappaB was observed in the EPO-treated rats.
Conclusion: Administration of EPO as a single dose before the onset of ischaemia produced a significant reduction in tubular injury, which was accompanied by a marked amelioration of renal functional impairment. The cytoprotective action of EPO against I/R injury seems to be associated with its anti-apoptotic action. Moreover, transcription factor NF-kappaB is likely to play a pivotal role in the pathophysiology of I/R renal injury and might have a key role in EPO-mediated protective effects.
Similar articles
- Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.
Yao JH, Li YH, Wang ZZ, Zhang XS, Wang YZ, Yuan JC, Zhou Q, Liu KX, Tian XF. Yao JH, et al. Clin Exp Pharmacol Physiol. 2007 Nov;34(11):1102-8. doi: 10.1111/j.1440-1681.2007.04674.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17880361 - Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation.
Jiang SH, Liu CF, Zhang XL, Xu XH, Zou JZ, Fang Y, Ding XQ. Jiang SH, et al. Cell Biochem Funct. 2007 May-Jun;25(3):335-43. doi: 10.1002/cbf.1395. Cell Biochem Funct. 2007. PMID: 17221834 - Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.
Hu L, Yang C, Zhao T, Xu M, Tang Q, Yang B, Rong R, Zhu T. Hu L, et al. J Surg Res. 2012 Jul;176(1):260-6. doi: 10.1016/j.jss.2011.06.035. Epub 2011 Jul 19. J Surg Res. 2012. PMID: 21816412 - Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin.
Sharples EJ, Thiemermann C, Yaqoob MM. Sharples EJ, et al. Nat Clin Pract Nephrol. 2005 Dec;1(2):87-97. doi: 10.1038/ncpneph0042. Nat Clin Pract Nephrol. 2005. PMID: 16932374 Review. - Erythropoietin in experimental acute renal failure.
Sharples EJ, Yaqoob MM. Sharples EJ, et al. Nephron Exp Nephrol. 2006;104(3):e83-8. doi: 10.1159/000094546. Nephron Exp Nephrol. 2006. PMID: 16837817 Review.
Cited by
- The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model.
Hong JP, Park SW. Hong JP, et al. Int Wound J. 2014 Aug;11(4):373-8. doi: 10.1111/j.1742-481X.2012.01100.x. Epub 2012 Oct 19. Int Wound J. 2014. PMID: 23078553 Free PMC article. - Intra-operative erythropoietin during laparoscopic partial nephrectomy is not renoprotective.
Olweny EO, Mir SA, Park SK, Tan YK, Faddegon S, Best SL, Gurbuz C, Cadeddu JA. Olweny EO, et al. World J Urol. 2012 Aug;30(4):519-24. doi: 10.1007/s00345-011-0760-6. Epub 2011 Sep 15. World J Urol. 2012. PMID: 21918797 - The first description of severe anemia associated with acute kidney injury and adult minimal change disease: a case report.
Qian Y, Mehandru SK, Gornish N, Frank E. Qian Y, et al. J Med Case Rep. 2009 Jan 23;3:20. doi: 10.1186/1752-1947-3-20. J Med Case Rep. 2009. PMID: 19166584 Free PMC article. - Suppression of Indoxyl Sulfate Accumulation Reduces Renal Fibrosis in Sulfotransferase 1a1-Deficient Mice.
Hou H, Horikawa M, Narita Y, Jono H, Kakizoe Y, Izumi Y, Kuwabara T, Mukoyama M, Saito H. Hou H, et al. Int J Mol Sci. 2023 Jul 11;24(14):11329. doi: 10.3390/ijms241411329. Int J Mol Sci. 2023. PMID: 37511089 Free PMC article. - Short-Term Diet Restriction but Not Alternate Day Fasting Prevents Cisplatin-Induced Nephrotoxicity in Mice.
Gunebakan E, Yalcin E, Dulger EC, Yigitbasi A, Ates N, Caglayan A, Beker MC, Sahin K, Korkaya H, Kilic E. Gunebakan E, et al. Biomedicines. 2020 Feb 3;8(2):23. doi: 10.3390/biomedicines8020023. Biomedicines. 2020. PMID: 32028692 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials